SMART (Symbicort [budesonide/formoterol] maintenance and reliever therapy): Reassure program for patients using Symbicort Turbuhaler as maintenance and reliever therapy in Korean clinical practice
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2008
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 05 Oct 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 05 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Sep 2007 New trial record.